Mind-NRG mind-nrg.com


Public list: Smart Money VCs (6326) Pharma Startups (6570) Neuroscience Startups (947)

Mind-NRG is devoted to the development of NRG-101 in psychiatric and neurologic diseases. NRG-101 is a neurotrophic factor with disease modifying potential that naturally crosses the blood-brain barrier through a receptor-mediated transport to reach its target in the brain. NRG-101 is being developed to treat disorders such as Parkinson's disease, Alzheimer's disease and schizophrenia.

Mind-NRG is devoted to the development of NRG-101 in psychiatric and neurologic diseases. NRG-101 is a neurotrophic factor with disease modifying potential that naturally crosses the blood-brain barrier through a receptor-mediated transport to reach...Show all

Company (Alive / Active)

All investors data 2 Investors

Phone: +41 22 737 00 00

Fax:

Rue de Jargonnant 2

 Geneva, CH-1207
 Switzerland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Mind-NRG $10M Sep 4, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Mind-NRG Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Use of neuregulin-β as an indicator and/or target Feb 25, 2011 Oct 01, 2013 Patent
Method of effecting neuroprotection using soluble neuregulin isoforms Oct 25, 2016 Application
Active soluble post-translationally modified neuregulin isoforms Dec 08, 2014 Application
Neuregulin isoforms, neuregulin polypeptides and uses thereof Nov 21, 2014 Application